July 15th, 2009
Posted by: admin
WASHINGTON (MedPage Today) — The FDA will require some immunosuppressant drug manufacturers to update product labels to reflect increased infection risk, an FDA release said today.
This entry was posted
on Wednesday, July 15th, 2009 at 3:15 am and is filed under Health news.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.